Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

BRENDA Home
show all | hide all No of entries

Information on EC 1.1.1.64 - testosterone 17beta-dehydrogenase (NADP+) and Organism(s) Rattus norvegicus and UniProt Accession O54939

for references in articles please use BRENDA:EC1.1.1.64
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
IUBMB Comments
Also oxidizes 3-hydroxyhexobarbital to 3-oxohexobarbital.
Specify your search results
Select one or more organisms in this record: ?
This record set is specific for:
Rattus norvegicus
UNIPROT: O54939
Show additional data
Do not include text mining results
Include (text mining) results
Include results (AMENDA + additional results, but less precise)
Word Map
The taxonomic range for the selected organisms is: Rattus norvegicus
The expected taxonomic range for this enzyme is: Bacteria, Eukaryota
Synonyms
17betahsd3, 17beta-hydroxysteroid dehydrogenase 3, 17beta-hsd 3, testosterone 17beta-dehydrogenase (nadp+), more
SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
17beta-hydroxysteroid dehydrogenase
-
17beta-hydroxysteroid dehydrogenase type 3
-
17-ketoreductase
-
-
-
-
17beta-hydroxysteroid dehydrogenase 3
-
-
17beta-hydroxysteroid dehydrogenase type 3
-
-
NADP-dependent testosterone-17beta-oxidoreductase
-
-
-
-
type 3 17beta-HSD
-
-
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
redox reaction
-
-
-
-
oxidation
-
-
-
-
reduction
-
-
-
-
PATHWAY SOURCE
PATHWAYS
-
-, -, -
SYSTEMATIC NAME
IUBMB Comments
17beta-hydroxysteroid:NADP+ 17-oxidoreductase
Also oxidizes 3-hydroxyhexobarbital to 3-oxohexobarbital.
CAS REGISTRY NUMBER
COMMENTARY hide
9028-63-1
-
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
androstenedione + NADPH + H+
testosterone + NADP+
show the reaction diagram
testosterone + NADP+
androstenedione + NADPH + H+
show the reaction diagram
-
-
-
?
17beta-estradiol + NADP+
estrone + NADPH
show the reaction diagram
androstenedione + NADPH + H+
testosterone + NADP+
show the reaction diagram
testosterone + NADP+
androst-4-ene-3,17-dione + NADPH + H+
show the reaction diagram
testosterone + NADP+
androstenedione + NADPH + H+
show the reaction diagram
-
-
-
-
r
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
androstenedione + NADPH + H+
testosterone + NADP+
show the reaction diagram
the two reactions 11beta-HSD1-dehydrogenase, EC 1.1.1.146, and 17beta-HSD3, EC 1.1.1.64, which utilize NADPH are competing for NADPH from the same cofactor pool. 11beta-HSD1-dehydrogenase serves as a NADPH-regenerating system that is tightly coupled in regulating 17beta-HSD3 reaction synthesizing testosterone. A cycle can exist whereby the NADPH produced by 11beta-HSD1 dehydrogenase can drive the reductase activity of 17beta-HSD3 and the NADP+ produced by 17beta-HSD3 and other enzymes involved in testosterone biosynthesis can drive the dehydrogenase activity of 11beta-HSD1
i.e. 4-androsten-17beta-ol-3-one
-
?
testosterone + NADP+
androstenedione + NADPH + H+
show the reaction diagram
-
-
-
?
17beta-estradiol + NADP+
estrone + NADPH
show the reaction diagram
androstenedione + NADPH + H+
testosterone + NADP+
show the reaction diagram
-
-
-
-
?
testosterone + NADP+
androst-4-ene-3,17-dione + NADPH + H+
show the reaction diagram
testosterone + NADP+
androstenedione + NADPH + H+
show the reaction diagram
-
-
-
-
r
COFACTOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(3alpha,5alpha)-3-[(2,5-dimethyl-4-{[2-(trifluoromethyl)phenyl]sulfonyl}piperazin-1-yl)methyl]-3-hydroxyandrostan-17-one
the inhibitor RM-532-105 seems to have difficulties in penetrating inside the testis and is concentrated in the testicular capsule. Therefore it is unable to inhibit the 17bets-HSD3 located inside the testis. At a higher concentration, RM-532-105 significantly decreases the level of testosterone and dihydrotestosterone in rat plasma, in vivo effects of the inhibitor in testis and plasma, detailed overview
(+)-gossypol
-
-
(-)-gossypol
-
-
(3alpha,5alpha)-3-([(2R,5S)-2,5-dimethyl-4-[2-(trifluoromethyl)benzene-1-sulfonyl]piperazin-1-yl]methyl)-3-hydroxyandrostan-17-one
-
48.8-92.0% inhibition at 0.0001-0.001 mM
(3R,5'R,10S,13S)-4',5'-dibenzyl-10,13-dimethyltetradecahydro-6'H-spiro[cyclopenta[a]phenanthrene-3,2'-[1,4]oxazinane]-6',17(2H)-dione
-
6.2-19.5% inhibition at 0.0001-0.001 mM
(3R,5'R,10S,13S)-5'-benzyl-10,13-dimethyltetradecahydro-6'H-spiro[cyclopenta[a]phenanthrene-3,2'-[1,4]oxazinane]-6',17(2H)-dione
-
58.2-90.4% inhibition at 0.0001-0.001 mM
(3R,5'S,10S,13S)-4',5'-dibenzyl-10,13-dimethyltetradecahydro-6'H-spiro[cyclopenta[a]phenanthrene-3,2'-[1,4]oxazinane]-6',17(2H)-dione
-
25.6-87.3% inhibition at 0.0001-0.001 mM
(3R,5'S,10S,13S)-5'-benzyl-10,13-dimethyltetradecahydro-6'H-spiro[cyclopenta[a]phenanthrene-3,2'-[1,4]oxazinane]-6',17(2H)-dione
-
18.5-63.2% inhibition at 0.0001-0.001 mM
(3S)-3,4-dibenzyl-1-oxa-4-azaspiro[5.5]undecan-2-one
-
47.3-92.1% inhibition at 0.0001-0.001 mM
(3S)-3-benzyl-1-oxa-4-azaspiro[5.5]undecan-2-one
-
24.2-24.3% inhibition at 0.0001-0.001 mM
1-(4-hydroxyphenyl)-butan-1-one
-
IC50: 0.08951 mM
1-(4-hydroxyphenyl)-ethanone
-
IC50: 1.70892 mM
1-(4-hydroxyphenyl)-heptan-1-one
-
IC50: 0.0784 mM
1-(4-hydroxyphenyl)-hexan-1-one
-
IC50: 0.01802 mM
1-(4-hydroxyphenyl)-nonan-1-one
-
IC50: 0.00286 mM
1-(4-hydroxyphenyl)-octan-1-one
-
IC50: 0.00652 mM
1-(4-hydroxyphenyl)-pentan-1-one
1-(4-hydroxyphenyl)-propan-1-one
-
IC50: 0.15056 mM
1-(4-hydroxyphenyl)-undeca-1-one
-
IC50: 0.00755 mM
5-[3,5-dichloro-4-(phosphonoxy)benzylidene]-3-(4-methoxyphenyl)-2-thioxo-1,3-oxazolidin-4-one
-
strong inhibitory activity on isoform 3beta-HSD3. When administered orally at a high dose of 100 mg/kg, compound shows approximately two times more potent testosterone-lowering effect against a positive control in the luteinizing hormone-releasing hormone-induced T production assay. The T-lowering effect continues at ca 10% level of control over 4 h after administration
7-hydroxyflavone
-
IC50: 0.06698 mM
baicalein
-
IC50: 0.18592 mM
bis(2-butoxyethyl) phthalate
-
potent inhibitor of testis 17beta-hydroxysteroid dehydrogenase type 3, additionally inhibits 3beta-hydroxysteriod dehydrogenase
dicyclohexyl phthalate
-
potent inhibitor of testis 17beta-hydroxysteroid dehydrogenase type 3, additionally inhibits 3beta-hydroxysteriod dehydrogenase
S-petasin
-
-
additional information
-
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.001
androstenedione
-
-
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.0285 - 0.05
bis(2-butoxyethyl) phthalate
0.0085 - 0.0165
dicyclohexyl phthalate
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.01093
(+)-gossypol
Rattus norvegicus
-
in PBS buffer, pH 7.2
0.00343
(-)-gossypol
Rattus norvegicus
-
in PBS buffer, pH 7.2
0.000014
(3alpha,5alpha)-3-([(2R,5S)-2,5-dimethyl-4-[2-(trifluoromethyl)benzene-1-sulfonyl]piperazin-1-yl]methyl)-3-hydroxyandrostan-17-one
Rattus norvegicus
-
pH and temperature not specified in the publication
0.000048
(3R,5'S,10S,13S)-4',5'-dibenzyl-10,13-dimethyltetradecahydro-6'H-spiro[cyclopenta[a]phenanthrene-3,2'-[1,4]oxazinane]-6',17(2H)-dione
Rattus norvegicus
-
pH and temperature not specified in the publication
0.000022
(3R,5'S,10S,13S)-5'-benzyl-10,13-dimethyltetradecahydro-6'H-spiro[cyclopenta[a]phenanthrene-3,2'-[1,4]oxazinane]-6',17(2H)-dione
Rattus norvegicus
-
pH and temperature not specified in the publication
0.08951
1-(4-hydroxyphenyl)-butan-1-one
Rattus norvegicus
-
IC50: 0.08951 mM
1.70892
1-(4-hydroxyphenyl)-ethanone
Rattus norvegicus
-
IC50: 1.70892 mM
0.0784
1-(4-hydroxyphenyl)-heptan-1-one
Rattus norvegicus
-
IC50: 0.0784 mM
0.01802
1-(4-hydroxyphenyl)-hexan-1-one
Rattus norvegicus
-
IC50: 0.01802 mM
0.00286
1-(4-hydroxyphenyl)-nonan-1-one
Rattus norvegicus
-
IC50: 0.00286 mM
0.00652
1-(4-hydroxyphenyl)-octan-1-one
Rattus norvegicus
-
IC50: 0.00652 mM
0.00497 - 0.06052
1-(4-hydroxyphenyl)-pentan-1-one
0.15056
1-(4-hydroxyphenyl)-propan-1-one
Rattus norvegicus
-
IC50: 0.15056 mM
0.00755
1-(4-hydroxyphenyl)-undeca-1-one
Rattus norvegicus
-
IC50: 0.00755 mM
0.06698
7-hydroxyflavone
Rattus norvegicus
-
IC50: 0.06698 mM
0.18592
baicalein
Rattus norvegicus
-
IC50: 0.18592 mM
0.0302 - 0.0825
bis(2-butoxyethyl) phthalate
0.0247 - 0.09
dicyclohexyl phthalate
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
0.0033
-
enzyme activity in smooth-surfaced microsomes
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
metabolism
the enzyme catalyzes the last step in the biosynthesis of the potent androgen testosterone (T), by stereoselectively reducing the C17 ketone of 4-androstene-3,17-dione (4-dione), with NADPH as cofactor
physiological function
the two reactions 11beta-HSD1-dehydrogenase, EC 1.1.1.146, and 17beta-HSD3, EC 1.1.1.64, which utilize NADPH are competing for NADPH from the same cofactor pool. 11beta-HSD1-dehydrogenase serves as a NADPH-regenerating system that is tightly coupled in regulating 17beta-HSD3 reaction synthesizing testosterone. A cycle can exist whereby the NADPH produced by 11beta-HSD1 dehydrogenase can drive the reductase activity of 17beta-HSD3 and the NADP+ produced by 17beta-HSD3 and other enzymes involved in testosterone biosynthesis can drive the dehydrogenase activity of 11beta-HSD1
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION?
DHB3_RAT
306
0
34223
Swiss-Prot
Secretory Pathway (Reliability: 1)
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
180000
-
gel filtration
GENERAL STABILITY
ORGANISM
UNIPROT
LITERATURE
very labile enzyme, loss of activity after storage for 2 weeks at -50°C
-
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Inano, H.; Tamaoki, B.
Testicular 17beta-hydroxysteroid dehydrogenas: molecular properties and reaction mechanism
Steroids
48
1-26
1986
Oryctolagus cuniculus, Ovis aries, Rattus norvegicus, Sus scrofa
Manually annotated by BRENDA team
Tamaoki, B-i.; Inano, H.
Testicular 17beta-hydroxysteroid dehydrogenase: its distribution, purification and properties
J. Steroid Biochem.
6
361-363
1975
Rattus norvegicus, Sus scrofa
Manually annotated by BRENDA team
Poirier, D.
Inhibitors of 17beta-hydroxysteroid dehydrogenases
Curr. Med. Chem.
10
453-477
2003
Canis lupus familiaris, Homo sapiens, Rattus norvegicus
Manually annotated by BRENDA team
Lota, R.K.; Dhanani, S.; Owen, C.P.; Ahmed, S.
Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a series of 4-hydroxyphenyl ketones as potential inhibitors of 17beta-hydroxysteroid dehydrogenase type 3 (17beta-HSD3)
Bioorg. Med. Chem. Lett.
16
4519-4522
2006
Rattus norvegicus
Manually annotated by BRENDA team
Parthasarathy, C.; Balasubramanian, K.
Effects of corticosterone deficiency and its replacement on Leydig cell steroidogenesis
J. Cell. Biochem.
104
1671-1683
2008
Rattus norvegicus (O54939)
Manually annotated by BRENDA team
Hu, G.X.; Zhou, H.Y.; Li, X.W.; Chen, B.B.; Xiao, Y.C.; Lian, Q.Q.; Liang, G.; Kim, H.H.; Zheng, Z.Q.; Hardy, D.O.; Ge, R.S.
The (+)- and (-)-gossypols potently inhibit both 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 in human and rat testes
J. Steroid Biochem. Mol. Biol.
115
14-19
2009
Homo sapiens, Rattus norvegicus
Manually annotated by BRENDA team
Harada, K.; Kubo, H.; Abe, J.; Haneta, M.; Conception, A.; Inoue, S.; Okada, S.; Nishioka, K.
Discovery of potent and orally bioavailable 17beta-hydroxysteroid dehydrogenase type 3 inhibitors
Bioorg. Med. Chem.
20
3242-3254
2012
Rattus norvegicus, Homo sapiens (P37058)
Manually annotated by BRENDA team
Yuan, K.; Zhao, B.; Li, X.W.; Hu, G.X.; Su, Y.; Chu, Y.; Akingbemi, B.T.; Lian, Q.Q.; Ge, R.S.
Effects of phthalates on 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 activities in human and rat testes
Chem. Biol. Interact.
195
180-188
2012
Rattus norvegicus, Homo sapiens (P37058)
Manually annotated by BRENDA team
Latif, S.A.; Shen, M.; Ge, R.S.; Sottas, C.M.; Hardy, M.P.; Morris, D.J.
Role of 11beta-OH-C(19) and C(21) steroids in the coupling of 11beta-HSD1 and 17beta-HSD3 in regulation of testosterone biosynthesis in rat Leydig cells
Steroids
76
682-689
2011
Rattus norvegicus (O54939)
Manually annotated by BRENDA team
Djigoue, G.B.; Kenmogne, L.C.; Roy, J.; Poirier, D.
Synthesis of 3-spiromorpholinone androsterone derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase type 3
Bioorg. Med. Chem. Lett.
23
6360-6362
2013
Rattus norvegicus
Manually annotated by BRENDA team
Roy, J.; Fournier, M.A.; Maltais, R.; Kenmogne, L.C.; Poirier, D.
Reprint of in vitro and in vivo evaluation of a 3beta-androsterone derivative as inhibitor of 17beta-hydroxysteroid dehydrogenase type 3
J. Steroid Biochem. Mol. Biol.
153
170-178
2015
Homo sapiens (P37058), Rattus norvegicus (O54939), Rattus norvegicus Sprague-Dawley (O54939)
Manually annotated by BRENDA team